Abstract: A combination of medicines are administered daily for the relief of the symptoms of an Anxiety Disorder or an Adjustment Disorder With Anxiety. The combination comprises a centrally-acting beta-blocker which passes the brain blood barrier, preferably the beta-blocker betaxolol, and a serotonin-enhancer, for example, the serotonin agonist buspirone or the serotonin reuptake inhibitor sertraline.

Abstract: A free-standing device for the testing of ECT (electroconvulsive therapy) instruments, and for training doctors in using such instruments, includes circuits to generate electrical wave forms which simulate the EEG (electroencephalograph) detectable brain waves, EMG (electromyograph) muscle activity and heart beats of a patient undergoing ECT. In one embodiment the ECT output leads of the ECT instrument are plugged into the device, the training doctor selects the ECT current and the device generates response EEG and EMG waveforms. It also measures the current and displays its measurement as a test of the accuracy of the stimulus selection controls of the ECT instrument.

Abstract: In non-convulsive magnetic stimulation therapy a patient is treated with magnetic pulses from a coil placed proximate the patient's head as a treatment of certain neurologic and psychiatric disorders. A set of EEG (electroencephalograph) electrodes on the patient's scalp are switched on during pauses in the electrical pulse train to the coil. If epilepsy-like brain wave spikes and/or sharp waves are detected by the EEG, a warning is given, treatment is halted and an anti-convulsive medicine may be administered.

Abstract: An oral protector, especially for use by patients during electroconvulsive therapy (ECT) consists of a flat unitary member which is preferably stamped from a flat sheet of material. The protector is elastic and formed of a closed-cell material, such as polyurethane plastic resin or artificial rubber. It has an elongated, generally elliptical shaped central opening which acts as an air passage.

Abstract: In medical convulsive therapy (CV), comprising electroconvulsive therapy (ECT) and magnetoconvulsive therapy (MCT), a computer system is used to analyze the effectiveness of the treatment. In one embodiment the effectiveness is determined by measuring the physiological effects on the heart (ECG) muscles (EMG) and brain (EEG).

Abstract: The compound betaxolol has the chemical formula:1-?4?2-cyclopropylmethoxy)ethyl!phenoxy!-3-?1-methylethyl)amino!-2-propanol .It is administered, preferably orally, once per day in 4-12 mg. tablets for the treatment of symptoms of anxiety disorder in human patients. Such symptoms include those present in Generalized Anxiety Disorder (GAD), which include somatic symptoms such as panic, palpitations and pounding heart.

Abstract: A spreader for particulate material, particularly for wet lime. The mechanism compresses a cover which is placed on the vertical shaft of a conventional spin spreader. The particulate material is placed on the cover and is vibrated into a hopper, then dispersed within the hopper and spread by blades mounted on the shaft.